Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1709 of 5804
-
New PET tracer could light up pancreatic tumors
Diagnosis Not yet recruitingThis clinical trial tests the safety, side effects, best dose and feasibility of using 64Cu-DOTA A2 scFv-Fc2 DM with positron emission tomography for the imaging of patients with PSCA-expressing pancreatic cancer that has spread to nearby tissue or lymph nodes (locally advanced) …
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
New drug shows promise for lung scarring in Long-Term safety trial
Disease control Not yet recruitingThe purpose of this study is to evaluate the long-term safety and tolerability of Admilparant in participants who completed participation in parent studies IM027-068 (for idiopathic pulmonary fibrosis (IPF)) and IM027-1015 (for progressive pulmonary fibrosis (PPF)).
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Cord blood stem cells could ease tough arthritis
Disease control Not yet recruitingThis is a phase 1, randomized, placebo-controlled, double-blind, single-dose, clinical trial examining the safety and biological effects of allogeneic fresh human umbilical cord tissue-derived mesenchymal stem cell product BX-U001, given by intravenous (IV) infusion, to rheumatoi…
Phase: PHASE1 • Sponsor: Baylx Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New strategies aim to boost PrEP access for black women
Prevention Not yet recruitingThis study will evaluate implementation strategies to address barriers and increase uptake of PrEP among Black cisgender women in Planned Parenthood of Illinois (PPIL) health centers.
Phase: NA • Sponsor: Rush University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 08:12 UTC
-
Could a lower dose of thyroid hormone be just as effective for advanced cancer?
Disease control Not yet recruitingMost thyroid cancers can be cured with surgery, sometimes with radioactive iodine therapy. However, some patients have cancer that has spread, and some have cancer that comes back after treatment. For those with remaining cancer, lowering TSH levels is recommended. This is becaus…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Decades-Long burn scar study seeks to improve future skin grafts
Knowledge-focused Not yet recruitingThe Swisskera project is a multicenter follow-up study at the three Swiss burn centers evaluating long-term outcomes after burn wound coverage with lab-grown epithelial grafts, specifically cultured epithelial autograft (CEA) and, where applicable, cultured dermal-epidermal autog…
Sponsor: University Children's Hospital, Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New patch could replace opioids for knee surgery pain
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if the NEUROCUPLE device can reduce pain and opioid use after primary unilateral total knee arthroplasty (TKA) in adults. The main questions it aims to answer are: * Does the NEUROCUPLE device reduce postoperative pain at rest during …
Phase: NA • Sponsor: Jacques E. Chelly • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Biodegradable artery graft could revolutionize leg bypass surgery
Disease control Not yet recruitingA prospective, single arm, non-randomized European feasibility study to evaluate the safety and performance of the XPAD conduit in patients with peripheral arterial occlusive disease (PAOD), scheduled to undergo elective lower-limb, above or below the knee, bypass surgery.
Phase: NA • Sponsor: Xeltis • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug AVM0703 tested for Life-Threatening lung failure
Disease control Not yet recruitingThis is a randomized, double-blinded, placebo-controlled study of AVM0703 administered as a single intravenous (IV) infusion to patients with moderate or severe immediately life-threatening Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 or influenza (A or B). The stud…
Phase: PHASE1 • Sponsor: AVM Biotechnology Inc • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
One shot instead of two? new IV iron aims to simplify anemia treatment
Disease control Not yet recruitingThe goal of this clinical trial is to see if a new intravenous iron formulation (Ferric Bepectate IV Injection) can treat adult patients with iron deficiency anemia (IDA) by increasing blood hemoglobin (Hb) as an established formulation (Ferric carboxymaltose). It will also learn…
Phase: PHASE3 • Sponsor: AFT Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a Micro-Dose of bone protein make dental implants safer and stronger?
Disease control Not yet recruitingThis study will compare the effect of standard-dose and micro-dose recombinant human bone morphogenetic protein-2 (rhBMP-2) with a placebo control on dental implant stability in the posterior mandible. Sixty patients requiring a single dental implant will be randomly assigned to …
Phase: NA • Sponsor: University of Baghdad • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can umbilical cord stem cells reverse frailty in the elderly?
Disease control Not yet recruitingThe purpose of this Phase I, open-label study is to evaluate the safety and tolerability of intravenous MiraMSC-FS-001 in older adults with mild to moderate frailty syndrome. MiraMSC-FS-001 is an investigational product consisting of allogeneic umbilical cord-derived mesenchymal …
Phase: PHASE1 • Sponsor: Miracle Biomedical Co., Ltd. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New nausea drug could replace standard ER treatment
Symptom relief Not yet recruitingThe study team proposes a double-blind, comparative effectiveness, randomized controlled trial (RCT) to address the following goal: to determine the relative efficacy and adverse event profile of fosaprepitant compared to the standard of care antiemetic metoclopramide. Fosaprepit…
Phase: PHASE4 • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New sperm prep method aims to boost IVF success
Disease control Not yet recruitingProspective, multicenter, randomized clinical study evaluating the safety of a novel sperm preparation method for in vitro fertilization (IVF), compared to standard sperm preparation procedures.
Phase: NA • Sponsor: Fecundis Lab SL • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can a chat with a nurse prevent gun injuries in kids?
Prevention Not yet recruitingIn this randomized controlled trial, researchers will assess the effectiveness and implementation of S.A.F.E. Firearm in the inpatient pediatric hospital setting. S.A.F.E. Firearm has been adapted for nurse-led delivery to parents/caregivers (hereafter, parents) of hospitalized y…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Laser surgery in the womb could let moms with vasa previa deliver naturally
Disease control TerminatedIn this research study, the investigators want to learn more about the safety and effectiveness of a fetal surgery, known as fetoscopic laser photocoagulation (FLP), for the treatment of a pregnancy condition called vasa previa (VP). Vasa previa is a pregnancy complication that h…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Freeze then ointment: new combo tackles precancerous skin spots
Disease control Not yet recruitingThe aim of the study is to evaluate the efficacy and safety of a combined approach of cryotherapy and tirbanibulin for the treatment of actinic keratosis of the scalp and forehead, repeated every 4 months. A higher rate of complete response is expected with this combination compa…
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Supplement mimics DASH diet to fight hypertension in african americans
Prevention Not yet recruitingIn the DASH (Dietary Approaches to Stop Hypertension) trials, a diet rich in fruits, vegetables, nuts and dairy products, and limited in fat content, was shown to be useful in controlling hypertension, particularly in African Americans (AA). Key components of such a diet are pota…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC
-
New tool aims to help heart failure patients get the right meds
Disease control Not yet recruitingThe goal of this clinical trial is to learn if a shared decision-making tool called SHARE-HF can help more people with heart failure receive guideline-recommended medications. The study includes adults with a type of heart failure called heart failure with reduced ejection fracti…
Phase: NA • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Mind over fatigue: could a 3-Day program tame long COVID?
Symptom relief Not yet recruitingLong COVID affects about 6 in 100 people after a COVID-19 infection. It can cause ongoing problems like ongoing tiredness, muscle pain, and "brain fog." We know very little about which treatments might be helpful for long COVID. The goal of this trial is to compare two treatment…
Phase: NA • Sponsor: McMaster University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC